Patents by Inventor Menglin YANG

Menglin YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of tegaserod in preparation of anti-tumor drug
    Patent number: 12364682
    Abstract: The present disclosure discloses the use of Tegaserod or a pharmaceutically acceptable salt thereof as a JAK-STAT3 signaling pathway inhibitor and an immunomodulator in the preparation of an anti-tumor drug. Tegaserod and the pharmaceutically acceptable salt thereof show a very excellent inhibitory effect on the growth of various tumor cells in vivo and in vitro, and are expected to be used in the treatment of various cancers.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: July 22, 2025
    Assignees: Qingdao Haiji Biomedicine Co., Ltd., MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO CO., LTD.
    Inventors: Jinbo Yang, Qiaoling Song, Chenyang Zhao, Lijuan Wu, Jun Zhao, Dan Yao, Yu Tang, Ximing Xu, Menglin Yang
  • APPLICATION OF TEGASEROD IN PREPARATION OF ANTI-TUMOR DRUG
    Publication number: 20220218666
    Abstract: The present disclosure discloses the use of Tegaserod or a pharmaceutically acceptable salt thereof as a JAK-STAT3 signaling pathway inhibitor and an immunomodulator in the preparation of an anti-tumor drug. Tegaserod and the pharmaceutically acceptable salt thereof show a very excellent inhibitory effect on the growth of various tumor cells in vivo and in vitro, and are expected to be used in the treatment of various cancers.
    Type: Application
    Filed: April 17, 2020
    Publication date: July 14, 2022
    Applicant: MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO CO., LTD.
    Inventors: Jinbo YANG, Qiaoling SONG, Chenyang ZHAO, Lijuan WU, Jun ZHAO, Dan YAO, Yu TANG, Ximing XU, Menglin YANG